Kim Stobbelaar
Overview
Explore the profile of Kim Stobbelaar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
143
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jacobs L, Leemans A, Stobbelaar K, Fransen A, Cos P, Delputte P
Viruses
. 2025 Jan;
16(12.
PMID: 39772158
Respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory tract infections in young children, elderly and immunocompromised patients worldwide. The RSV fusion (F) protein, which has 5-6...
2.
Stobbelaar K, De Winter B, Smet A, Verhulst S, Delputte P
Microbiol Spectr
. 2024 Sep;
12(11):e0189624.
PMID: 39297653
No abstract available.
3.
Bonneux B, Jacoby E, Ceconi M, Stobbelaar K, Delputte P, Herschke F
Antiviral Res
. 2024 Jul;
229:105948.
PMID: 38972604
Respiratory syncytial virus (RSV) causes respiratory disease and complications in infants, the elderly and the immunocompromised. While three vaccines and two prophylactic monoclonal antibodies are now available, only one antiviral,...
4.
Favere K, Van Hecke M, Eens S, Bosman M, Stobbelaar K, Hotterbeekx A, et al.
Cardiovasc Pathol
. 2024 May;
72:107652.
PMID: 38750778
Background And Aims: Viral infections are the leading cause of myocarditis. Besides acute cardiac complications, late-stage sequelae such as myocardial fibrosis may develop, importantly impacting the prognosis. Coxsackievirus B3 (CVB)-induced...
5.
Schaerlaekens S, Jacobs L, Stobbelaar K, Cos P, Delputte P
Vaccines (Basel)
. 2024 Jan;
12(1).
PMID: 38250910
Respiratory Syncytial Virus (RSV) poses a significant global health concern as a major cause of lower respiratory tract infections (LRTIs). Over the last few years, substantial efforts have been directed...
6.
Jacobs L, Stobbelaar K, Heykers A, Cos P, Delputte P
Antibodies (Basel)
. 2023 Oct;
12(4).
PMID: 37873859
Respiratory Syncytial Virus (RSV) is a significant cause of lower respiratory tract infections in the young, the elderly, and in immunodeficient patients. As such, the virus represents an important cause...
7.
Sacconnay L, De Smedt J, Rocha-Perugini V, Ong E, Mascolo R, Atas A, et al.
Sci Transl Med
. 2023 Aug;
15(710):eadg6050.
PMID: 37611082
The RSVPreF3-AS01 vaccine, containing the respiratory syncytial virus (RSV) prefusion F protein and the AS01 adjuvant, was previously shown to boost neutralization responses against historical RSV strains and to be...
8.
Stobbelaar K, Mangodt T, Van der Gucht W, Delhaise L, Andries J, Gille V, et al.
Microbiol Spectr
. 2023 May;
11(3):e0436822.
PMID: 37212711
The respiratory syncytial virus (RSV) represents the leading cause of viral lower respiratory tract infections (LRTI) in children worldwide and is associated with significant morbidity and mortality rates. The clinical...
9.
Van Brusselen D, De Troeyer K, Ter Haar E, Vander Auwera A, Poschet K, Van Nuijs S, et al.
Eur J Pediatr
. 2021 Jan;
180(6):1969-1973.
PMID: 33517482
Stay-at-home orders, physical distancing, face masks and other non-pharmaceutical interventions (NPIs) do not only impact COVID-19, but also the dynamics of various other infectious diseases. Bronchiolitis is a clinically diagnosed...
10.
Van der Gucht W, Stobbelaar K, Govaerts M, Mangodt T, Barbezange C, Leemans A, et al.
Viruses
. 2019 Nov;
11(11).
PMID: 31698728
Respiratory Syncytial Virus (RSV) is a very important viral pathogen in children, immunocompromised and cardiopulmonary diseased patients and the elderly. Most of the published research with RSV was performed on...